Reported Reactions

Devices › Device types

FDA product code GKT · class 2 · Hematology

Separator, automated, blood cell, diagnostic: medical device reports filed with FDA

6,581 reports carry this product code, 1993–2026; 6 brands with a page.

6,581
reports with this product code
0% of all MAUDE reports
155
reports, 12 months to August 2026
341 in the 12 months before
77.2%
classified as malfunction
62.3% across all reports
4%
classified as death, as reported
0.9% across all reports

Product code GKT is FDA's classification for "Separator, automated, blood cell, diagnostic" (hematology panel), a class 2 device. 6,581 medical device reports carry this product code, 0% of the MAUDE database, from May 1993 to August 2026.

155 reports arrived in the 12 months to August 2026, down 55% from 341 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (77.2%), injury (14.1%) and death (4%). 6 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Trima Accel4,240890.2%93.1%
Spectra Optia397704.9%56.3%
Cobe Spectra Blood Collection28704.2%18.8%
Pcs2 Plasma Collection System264028.8%59.1%
Trima Accel Enhanced Plt Pls Rbc Set4900%79%
Baxter133.8%54.2%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Terumo Bct5,15478.3%
Haemonetics5458.3%
Baxter Healthcare3765.7%
Terumo30%
Beckman Coulter20%
Gambro Healthcare20%
Fresenius USA10%

Reports by month, five years

04488Sep 2021: 29Oct 2021: 38Nov 2021: 31Dec 2021: 332022Jan 2022: 41Feb 2022: 40Mar 2022: 28Apr 2022: 42May 2022: 33Jun 2022: 45Jul 2022: 32Aug 2022: 35Sep 2022: 36Oct 2022: 26Nov 2022: 41Dec 2022: 462023Jan 2023: 37Feb 2023: 45Mar 2023: 45Apr 2023: 20May 2023: 18Jun 2023: 25Jul 2023: 23Aug 2023: 21Sep 2023: 33Oct 2023: 22Nov 2023: 34Dec 2023: 202024Jan 2024: 26Feb 2024: 27Mar 2024: 37Apr 2024: 37May 2024: 44Jun 2024: 37Jul 2024: 28Aug 2024: 28Sep 2024: 30Oct 2024: 32Nov 2024: 30Dec 2024: 882025Jan 2025: 21Feb 2025: 21Mar 2025: 10Apr 2025: 25May 2025: 29Jun 2025: 11Jul 2025: 16Aug 2025: 28Sep 2025: 15Oct 2025: 18Nov 2025: 18Dec 2025: 212026Jan 2026: 20Feb 2026: 12Mar 2026: 5Apr 2026: 5May 2026: 10Jun 2026: 15Jul 2026: 10Aug 2026: 6

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death4%266
Injury14.1%931
Malfunction77.2%5,082
Other1.3%86
Not given3.3%216

Who filed

Manufacturer report97.4%6,413
Voluntary report1.4%91
User facility report0%0
Distributor report0%1
Not given1.2%76

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
High test results1,33320.3%
Insufficient device problem information1,17317.8%
Device operates differently than expectedthe device behaved unexpectedly5057.7%
High readingsreadings were too high2583.9%
Mechanical problema mechanical problem1652.5%
Device slipped1502.3%
Device displays incorrect message1432.2%
Improper or incorrect procedure or method1422.2%
Disposable1241.9%
Fluid/blood leak1071.6%
Contamination of device ingredient or reagent1061.6%
Reactiona reaction, type not specified911.4%
Thermal decomposition of device891.4%
Air leak841.3%
Incorrect or inadequate test results821.2%
Incorrect, inadequate or imprecise result or readings821.2%
Inaccurate flow rate771.2%
Device handling problem761.2%
Temperature problem671%
Patient-device incompatibilitythe device did not suit the patient641%

Questions about separator, automated, blood cell, diagnostic reports

What is product code GKT?

FDA's classification code for "Separator, automated, blood cell, diagnostic", class 2, reviewed by the hematology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

6,581 reports through August 2026, 155 of them in the latest 12 months.

Which brands appear most often?

Trima Accel (4,240), Spectra Optia (397), Cobe Spectra Blood Collection (287), Pcs2 Plasma Collection System (264) and Trima Accel Enhanced Plt Pls Rbc Set (49). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.